The Difference in Barriers to Colorectal Cancer Screening Between Men and Women in the 45-55-Year Age Group by Davis, Maren Christina
Minnesota State University, Mankato 
Cornerstone: A Collection of Scholarly 
and Creative Works for Minnesota 
State University, Mankato 
All Theses, Dissertations, and Other Capstone 
Projects 
Graduate Theses, Dissertations, and Other 
Capstone Projects 
2020 
The Difference in Barriers to Colorectal Cancer Screening 
Between Men and Women in the 45-55-Year Age Group 
Maren Christina Davis 
Minnesota State University, Mankato 
Follow this and additional works at: https://cornerstone.lib.mnsu.edu/etds 
 Part of the Community Health and Preventive Medicine Commons, and the Public Health Education 
and Promotion Commons 
Recommended Citation 
Davis, M. C. (2020). The difference in barriers to colorectal cancer screening between men and women in 
the 45-55-year age group [Master’s thesis, Minnesota State University, Mankato]. Cornerstone: A 
Collection of Scholarly and Creative Works for Minnesota State University, Mankato. 
https://cornerstone.lib.mnsu.edu/etds/1025/ 
This Thesis is brought to you for free and open access by the Graduate Theses, Dissertations, and Other Capstone 
Projects at Cornerstone: A Collection of Scholarly and Creative Works for Minnesota State University, Mankato. It 
has been accepted for inclusion in All Theses, Dissertations, and Other Capstone Projects by an authorized 





The Difference in Barriers to Colorectal Cancer Screening Between Men and Women in 




Maren Christina Davis 
 
A Thesis Submitted in Partial Fulfillment of the  
Requirements for the Degree of 
Master of Science  
In 
Wellness Coaching and Disease Prevention 
 
 









May 04, 2020 
 
The Difference in Barriers to Colorectal Cancer Between Men and Women in the  
45-55-Year Age Group 
 
Maren C. Davis 
 




















“The miracle is not that I finished. The miracle is that I had the courage to start.”  
~ John Bingham 
This thesis would never have happened without the unconditional love, 
inspiration, and encouragement I received from my husband and kids. Scott, Wyatt, 
Gavin, and Cassidy - thank you for believing in me, holding me up, drying my tears, 
sacrificing family time and fun events, and cheering for me without question. I am 
immensely grateful for you as well as Mom and Dad, Sharon, Karen, and Annie.  
I would also like to thank Mary Kay for being the light on some pretty dark days 
and the best coach and study buddy I could ask for, and for never hesitating to push me 
to get things done or talk to me in the middle of the night because I needed this, that, or 
the other. God blessed each of us richly with this friendship.   
A big thank you to Dr. and Mrs. Bhatti for their support and for allowing 
distribution of my survey at their two clinic sites without question or hesitation.  
Finally, I would like to thank my committee members for their wisdom, guidance, 
and encouragement throughout this process and when I needed it most. Thank you, Dr. 
Kelly Krumwiede, for being a part of my educational journey for a second time, and for 
supporting me without hesitation. Thank you, Dr. Mary Kramer, for being my advisor 
and for believing in me when I did not. Lastly, thank you, Dr. Joseph Visker, for your 
passion, direction, and patience in seeing me through the good, the bad, and the 
pandemic. I am forever grateful for the opportunity to work with each one of you.  
ii 
 
Table of Contents 
Chapter One ……………………………………………………………………………………………….…….……...1 
Introduction ……………………………………………………………………………………….….…....1 
Statement of the Problem ……………………………………………………………….…….….….2 
Factors Contributing to the Problem ……………………………………………………….……3 
Significance of the Problem ……………………………………………………………….….….….4 
Purpose of the Study ……………………………………………………………………….……………5 





Chapter Two …………………………………………………………………………………………………….……….9 
Review of Literature …………………………………………………………………………….………9 
Introduction ………………………………………………………………………………………….….….9 
Colorectal Cancer Biology and Epidemiology ……………………………………………....9 
Colorectal Cancer Staging ……………………………………………………………………….….12 
Risk Factors for Colorectal Cancer ………………………………………………….….……….13 
Colorectal Cancer Screening Practices ……………………………….….………….….……19 
Screening Barriers ……………………………………………………………………………….….….21 
Importance of Screening and Prevention …………………………………………….….…22 
iii 
 
Gender-Specific Differences in Attitudes Toward Colorectal Cancer …….…….23 
Summary ………………………………………………………………………………………….…….....24 
Chapter Three ………………………………………………………………………………………………….………25 
Methodology ………………………………………………………………………………………….….25 
Introduction ……………………………………………………………………………………………….25 
Research Questions ……………………………………………………………………………………25 
Research Design …………………………………………………………………………………………25 
Sample Selection ……………………………………………………………………………………....26 
Data Collection Procedures …………………………………………………………………….….27 
Instrumentation …………………………………………………………………………………………28 
Validity and Reliability …………………………………………………………………………….….30 
Data Analysis ………………………………………………………………………………………….….31 
Summary ……………………………………………………………………………………………………33 
Chapter Four ……………………………………………………………………………………………………………34 
Results ……………………………………………………………………………………………………….34 
Introduction ……………………………………………………………………………………………….34 
Demographics of the Sample ………………………………………………………………….….34 
Assessment of Research Questions …………………………………………………………….35 
Summary ……………………………………………………………………………………………………43 
Chapter Five …………………………………………………………………………………………………………….45 






Recommendations for Healthcare Providers ………………………………………………50 



















List of Tables 
Table 1 ...…………………………………………………………………….………………………………………….33 
Table 2 ……………………………………………………………………………………………………………….….36 
Table 3 ……………………………………………………………………………………………………………….….37 
Table 4 ……………………………………………………………………………………………………………….….40     
Table 5 ……………………………………………………………………………………………………………….….42  
















THE DIFFERENCE IN BARRIERS TO COLORECTAL CANCER SCREENING BETWEEN MEN 
AND WOMEN IN THE 45-55-YEAR AGE GROUP  
 
MAREN C. DAVIS 
 
A THESIS SUBMITTED IN PARTIAL FULFILMENT OF THE 
REQUIREMENTS FOR THE DEGREE OF  
MASTER OF SCIENCE IN WELLNESS COACHING AND DISEASE PREVENTION  
 





Statement of the Problem: Adults, 50 years or older, should have a screening 
colonoscopy every ten years and fecal immunochemical test (FIT) every year.  However, 
close to 22 million adults between the ages of 50-75 in the U.S. have never been 
screened for colorectal cancer, which delays treatment and can be fatal if the cancer is 
not found in time. 
Procedure: This study used a descriptive, cross-sectional, survey-based design and a 
convenience sample of men and women between 45 and 55 years old to assess 
colorectal screening practices, barriers to screening, and knowledge levels about 
colorectal cancer screening.  
Findings: A total of 161 survey participants, mostly non-Hispanic Caucasian/white 
females, met the eligibility criteria. Just over half have had a colonoscopy and some 
before age 50 but sigmoidoscopies and use of home stool blood tests were few. The 
greatest barriers were no doctor’s order and not being told to get screened and the 
least were lack of provider and other types of colon exams. Almost half complained that 
the prep was too painful, unpleasant, or embarrassing. Overall, the barriers were 
perceived as greater for women than for men. More participants knew about what 
starting age CRCS is recommended for but there was a significant knowledge deficit 
related to how often screening should occur, which presents an important opportunity 
for education.  
Conclusions and Recommendations: Colorectal cancer should not be treated any 
differently than prostate or breast cancer and more public health campaigns are needed 
to assure patients that screening equals prevention. Automatic reminders to EMRs can 
serve both, the patient, and the provider. Adding health coaches to the healthcare team 
permanently will empower patients to take responsibility in their own healthcare and 






Colorectal cancer (CRC) is projected to claim over 50,000 lives in the United 
States in 2019 and more than 145,000 new colon and rectal cancer diagnoses are 
anticipated (American Cancer Society [ACS], 2019). The risk for developing colorectal 
cancer in a person’s lifetime is “about 1 in 22 (4.49%) for men and 1 in 24 (4.15%) for 
women” (ACS, 2019, para. 2). However, timely compliance with screening 
recommendations can prevent most colorectal cancer occurrence and over half of 
colorectal cancer deaths (Cossu, Saba, Minerba, & Mascalchi, 2018). 
DiPietro, DeLoia, and Barbiero (2019) related that cancer happens because of 
uninhibited cell growth and, in the case of colorectal cancer, those cells typically form in 
the inner lining of the colon or rectum. The authors likewise stated that cancer typically 
originates in neoplastic polyps, which can be benign, precancerous, or malignant. Since 
colon and rectal cancers are so closely related in their location, appearance, and 
presentation, they are often referred to collectively as colorectal cancer, but they can be 
separated for research and treatment purposes (Van der Sijp et al., 2016). Rectal tumors 
can be found in the rectum, which extends about six inches from the anal opening and 
grow to extend past the rectal wall to surrounding organs (Paschke et al., 2018). 
Paschke et al. (2018) expand by proposing that, even though the colon and rectum are 
connected as part of the large bowel, colon cancer and rectal cancer should be 
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separated as two different diseases because of location within the body, potential 
complications, rate at which a cure is possible, and difference in surgical approaches.  
Colorectal cancer screening (CRCS) can be accomplished by structural exams or 
via stool-based tests (Issa & Noureddine, 2017). As noted by the ACS (2019), CRCS tools 
include direct visualization of the length of the colon wall via colonoscope during a 
colonoscopy. A shorter version of the colonoscopy, the flexible sigmoidoscopy, only 
provides visualization of the lower third of the colon. The shorter version is not done as 
frequently because much of the colon is skipped, which means that polyps and possible 
cancer can be missed. The ACS (2019) furthermore mentioned that a virtual 
colonoscopy via computed tomography (CT) scan can be done but it requires a full 
bowel prep, there is radiation exposure, and if polyps are found, they cannot be 
removed during this procedure and the patient must undergo colonoscopy after all. 
Lastly, there are three different types of at-home stool sampling methods that all have 
the potential to miss polyps and if positive, must be followed up with a colonoscopy 
(ACS, 2019). 
Statement of the Problem 
The recommendations for CRCS are that patients at 50 years of age start having a 
screening colonoscopy every ten years and fecal immunochemical test (FIT) every year 
(Rex et al., 2017). The ACS (2019) recommends screening at age 45 for people who are 
of average risk. Changes to those recommendations by the ACS are based on personal or 
family history of colon polyps and/or colon cancer, personal history of inflammatory 
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bowel disease, and the findings of above-mentioned tests. ACS recommendations also 
state that a positive fecal immunochemical test triggers a follow-up colonoscopy and 
that certain types of polyps, when found during colonoscopy or flexible sigmoidoscopy, 
indicate the need for a three-year follow-up colonoscopy, rather than ten (ACS, 2019). 
Colonoscopies are, therefore, not just preventative but also diagnostic procedures. 
However, in the United States, “21.7 million adults aged 50 to 75 years […] have never 
been screened for CRC [colorectal cancer]” (Centers for Disease Control and Prevention 
[CDC], 2019, para. 2), which delays treatment and can be fatal if the cancer is not found 
in time.  
Factors Contributing to the Problem 
 Cossu, Saba, Minerba, and Mascalchi (2018) conveyed several elements 
contributing to the delay of CRCS, including family, cultural, and socioeconomic 
background; being male; not being able to get an appointment in a timely manner; 
mental health concerns; level of education; and being obese. Additionally, the authors 
pointed out that a knowledge deficit regarding the process of screening could create 
fear of and anxiety over what the results may be or if there is any pain, and 
embarrassment and helplessness could lead to low screening participation. Honein-
AbouHaidar et al. (2016) similarly reported little awareness, understanding, and 
knowledge of colorectal cancer and the purpose of CRCS; fear of cancer, screening 
results, and possible outcomes related to a cancer diagnosis; poor attitudes and shame 
toward CRCS; questionable efficacy of CRCS; no sense of urgency to get screened 
4 
 
because of life responsibilities, scheduling conflicts, transportation issues, being unable 
to find a person to accompany the patient, and a perception that other cancers might be 
more important to screen for; insufficient health literacy; language barriers; and a 
threat to masculinity among men as barriers to receive CRCS. Hasan et al. (2017) added 
questionable safety, high cost, and low education levels to a list akin to the two 
mentioned above. However, other reasons for delaying CRCS may exist and need to be 
explored. 
Significance of the Problem 
Colorectal cancer is the third most frequently diagnosed cancer in men and 
women in the U.S. and the second leading cause of cancer death in men and women 
combined (ACS, 2019). Cossu et al. (2018) noted that, although there is a downward 
trend, colorectal cancer is still one of the most prevalent reasons for cancer death and 
illness globally. This type of cancer is preventable with timely screening at regular 
intervals and chances for treatment and survival increase if the cancer is found and 
diagnosed early (Wang et al., 2012). Nevertheless, about one third of adults aged 50 to 
75 are not up to date with screening and more than 25% have never had a colonoscopy 
screening (CDC, 2016). Overall survival and health-related quality of life in colorectal 
cancer patients are influenced by race, marital status, level of education, age, income, 
and alcohol use (Reyes et al., 2017). Insurance and socioeconomic status as well as the 
number of comorbidities an individual has been diagnosed with have some bearing on 
survival (Tannenbaum, Hernandez, Zheng, Sussman, & Lee, 2014). Additionally, survival 
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is greatly dependent on what stage the cancer was diagnosed at and if it has 
metastasized (Haggar & Boushey, 2009). Colorectal cancer related mortality is also 
influenced by the location of the primary tumor because cancer in the right colon is less 
prevalent but has worse outcomes (Peeters et al., 2018).  
The age at which people get diagnosed with colon cancer is dropping and the 
prevalence of colorectal cancer in adults under 40 years of age is growing (Campos, 
2017). Imperiale, Kahi, and Rex (2018) pointed out a 22% rise in colorectal cancer 
diagnoses in individuals less than 50 years of age in the years between 2000 and 2013. 
Therefore, the recommended screening age was lowered to age 45 in 2018. However, if 
more than a quarter of screening-eligible adults are not having their colonoscopies, then 
the number of missed colon cancer cases and, ultimately death, also increases (CDC, 
2016). The U.S. government set goals to reach 70.5% of adults to receive colorectal 
cancer screening as part of the Healthy People 2020 initiative, which is a science-based 
10-year agenda for the betterment of the health of all Americans (Department of Health 
and Human Services [DHHS], 2019).  
Purpose of the Study 
The purpose of this study is to assess the extent to which participants received 
their primary CRCS by the recommended age and barriers that prevented timely CRCS. 
Furthermore, this study will evaluate the difference in barriers for timely initial CRSC for 
men compared to women. The information obtained from this study is of critical 
importance for public health campaigns to increase the number of people who have 
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timely initial CRCS. It will also be useful for healthcare providers to help remove the 
barriers for individuals to receive screening.  
Research Questions 
1. What are the colorectal cancer screening practices among males and females, 
aged 45-55? 
2. What potential barriers exist that prevent individuals from undergoing timely 
colorectal cancer screening? 
3. What are the knowledge levels of colorectal cancer screening among those who 
have and have not received screening? 
Limitations  
1. The time (three weeks on social media and two weeks of GI clinic distribution) in 
which the study was conducted limited responses.  
2. The geographical area of distribution was limited due to the size of the study. 
3. The study only focused on a limited age group.    
4. Males as well as ethnic and racial groups were underrepresented. 
5. Socioeconomic status and education level was not addressed.  
6. Reasons for early CRCS were not included.  
7. Other CRCS methods were left out. 
Delimitations  
1. The study was limited to men and women between the ages of 45 and 55 years 
old, which is the recommended age at which to start CRCS.  
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2. Data collection was limited to a portion of the spring semester 2020.  
3. Participants were limited to those who can read and understand English. 
Assumptions  
1. Participants can understand the survey questions and follow the directions 
provided to them. 
2. Participants are honest in answering the survey questions. 
Definitions  
• Adenoma: a benign tumor that originates in the epithelial tissue of a gland or 
gland-like structure (National Cancer Institute [NCI], n.d.) 
• Benign: non-cancerous (NCI, n.d.) 
• Bowel prep: elimination of all solid matter from the intestines by elimination of 
solid food intake for the duration of the prep and use of laxative medications 
(American Gastroenterological Association [AGA], 2020) 
• Colonoscopy: visual inspection of the inside lining of the colon from cecum to 
anus by use of colonoscope, a flexible tube with a light, camera, and hole to 
insert instruments for polyp removal at the tip (NCI, n.d.) 
• Colorectal cancer screening: is used to try to find cancer before any signs or 
symptoms appear but is referring to colonoscopies for the purpose of conducting 
this study (American Society of Clinical Oncology [ASCO], 2019) 
• Epithelial tissue: the thin lining of all body surfaces, hollow organs, and body 
cavities and the major tissue found in glands (NCI, n.d.) 
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• Flexible sigmoidoscopy: visual inspection of the inside lining of the last third of 
the colon by use of colonoscope (ACSO, 2019) 
• Home stool blood test: a test that detects hidden blood in the stool which could 
be an indicator for some type of bleeding in the digestive tract and warrants 
further investigation if results are positive (ACSO, 2019) 
• Malignant: cancerous with the potential to extend and invade other areas of the 
body (NCI, n.d.) 
• Neoplastic: a new and abnormal formation of tissue, may be cancerous or non-
cancerous (NCI, n.d.) 
• Polyp: a flat, or finger-like projection on the inside lining of the colon wall (NCI, 
n.d.) 
• Polypectomy: the surgical removal of a polyp (NCI, n.d.) 












Review of Literature 
Introduction 
The purpose of this study was to assess the extent to which participants received 
their primary CRCS by the recommended age and barriers that prevented timely CRCS. 
Furthermore, this study evaluated the difference in barriers for timely initial CRSC for 
men compared to women. This chapter provides relevant literature concerning 
colorectal cancer epidemiology, risk factors, screening practices, barriers to screening, 
and the importance of screening and prevention.  
Colorectal Cancer Biology and Epidemiology  
Colorectal cancer develops gradually. It begins with a growth, typically referred 
to as a polyp, and can, in time, become cancerous (Ünal & Ozturk, 2015). Ahmed, 
Johnson, Ahmed, and Iqbal (2014) stated that all colorectal cancers originate from small 
polyps. Winawer et al. (1997) added that cancer typically does not develop in the 
absence of adenomas. Growth patterns apart from adenomatous polyps are called 
serrated polyps and occur less often but present similar risk for cancer development, 
although only a fraction of all colorectal polyps will change into colorectal cancer (Øines, 
Helsingen, Bretthauer, & Emilsson, 2017). Winawer et al. (1997) described the 
progression from adenomatous polyps to colorectal cancer as slow and happening over 
the span of many years. Once cancer has developed, it is categorized by the extent of 
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growth from the original site in the inside lining of the colon wall to the outside lining, 
nearby lymph nodes, and other structures or organs in the body (Winawer et al., 1997).  
Colorectal cancer was found to be one of the primary reasons for cancer-related 
illness and death (Kolligs, 2016) and the third most frequently diagnosed as well as the 
third deadliest cancer in the United States (Kolligs, 2016). Marley and Nan (2016) 
reported that approximately 135,430 new cases were diagnosed in 2017 and 
approximately 50,260 deaths occurred in the same year. Brenner, Kloor, and Pox (2014) 
observed similar statistics on a global scale, describing colorectal cancer as the fourth 
most common oncological cause of death. Aran, Victorino, Thuler, and Ferreira (2016) 
suggested there are an estimated 753,000 worldwide colorectal cancer deaths per year 
and about 814,000 new cases for men and 664,000 for women in 2015. Favoriti et al. 
(2016) remarked that mortality rates were significantly different by gender as well as by 
race, with the latter likely due to socioeconomic diversity. The incidence rates account 
for 9.7% of all cancer incidents worldwide (Aran, Victorino, Thuler, & Ferreira, 2016).  
The above-mentioned findings substantiate that colorectal cancer constitutes 
the third deadliest cancer in men and women, only following prostate and lung cancer 
and breast and lung cancer in the United States respectively. However, even though 
estimations accounted for 1,177,556 of U.S. residents to have lived with a colorectal 
cancer diagnosis in 2013, those numbers were noted to be dwindling (Marley & Nan, 
2016). Rawla, Sunkara, and Barsouk (2019) said that incidence and death rates in 
persons over 50 years of age were decreasing in the United States and that death rates 
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have fallen significantly from 1975 to 2015. A study by Siegel et al. (2017) revealed 
similar results, where the authors elaborated on the difference being due to an increase 
in general acceptance of colorectal cancer screening. Siegel et al. (2017) also noticed a 
change where “receipt of a colonoscopy in the past 10 years increased from 14% in 2000 
to 41% in 2013 among individuals ages 50 to 54 years, from 16% to 52% in those ages 55 
to 59 years, and from 25% to 63% in those ages 65 years and older” (p. 189). Other 
reasons for a fall in incidence and mortality rates were said to be declining use of 
tobacco products, especially cigarettes, and high consumption of red and processed 
meat, as well as increasing use of aspirin (Siegel et al., 2017). Brenner, et al. (2014) 
attributed the change in direction to the fact that more individuals had polyps removed 
during sigmoidoscopy and colonoscopy.  
Another noteworthy characteristic of colorectal cancer is to consider that the 
age at first diagnosis is dropping (Rawla, Sunkara, & Barsouk, 2019). Aran et al. (2016) 
predicted that there will be a rise in new colorectal cancer diagnoses in the 20-49-year 
age group by 2030. Additionally, it was noted that there seems to be a disparity in 
incidence rates by geographical location, with the higher numbers in more developed 
area as well as in certain ethnicities. Over half of the global incidence of colorectal 
cancer was prevalent in developed countries (Kolligs, 2016). Favoriti et al. (2016) 
credited the reasoning behind that to varying exposures of diet and environment to 
those who are genetically more susceptible, while Siegel et al. (2017) attributed lifestyle 
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changes, such as unhealthy dietary patterns, overweight and obesity, and being 
physically inactive, to the finding. 
The five-year survival rate of colorectal cancer has been noted to be near 66% in 
high-income countries around the world, while lower-income countries have survival 
rates that are more than 16% lower (Brenner, Kloor, & Pox, 2014). Race, ethnicity, age, 
and progression of disease at time of diagnosis all play a role in survival, because 
colorectal cancer is detected in a timelier fashion and the treatment for it has been 
more developed (Favoriti et al., 2016). Furthermore, mortality reduction was due to 
advance in treatment, variations in risk factors, and increasing participation in screening 
procedures (Siegel et al., 2017).  
Colorectal Cancer Staging 
The staging of colorectal cancer encompasses how deep into the colon wall the 
cancer has grown (T stage), whether there is lymph node involvement (N stage), and any 
metastases (M stage) (Park, Kim, Lee, Lee, & Han, 2017). Appropriate treatment of 
colorectal cancer is determined by the staging of the disease through use of radiologic 
imaging like computed tomography (CT) scans, magnetic resonance imaging (MRI), 
transrectal ultrasound, or positron emission tomography (PET) scans (Lee & Lee, 2016). 
Vega, Valentín, and Cubiella (2015) suggested that whether the outcome is positive or 
negative as treatment is started is also dependent on the stage of the tumor. Correct 




Risk Factors for Colorectal Cancer 
Colorectal cancer does not have one single specific cause but rather, there are 
multiple elements involved in the development of the disease (Aran et al, 2016). Among 
the most commonly named risk factors for colorectal cancer, which can accumulate 
during the lifespan of any individual, are environmental influences, specifically 
sedentary lifestyle, overweight and obesity, smoking, excessive alcohol use, and a diet 
rich in processed meat and cholesterol and lacking fiber, folic acid, and vitamin B6, as 
well as low socioeconomic status and living in countries with limited healthcare 
resources (López, Albero, & Rodríguez-Montes, 2014). Winawer et al. (1997) cited 
having one or more relative with a history of colorectal cancer as one element that 
could increase the risk of also getting the disease. Kolligs (2016) estimated that 30%-
50% of the risk for colorectal cancer development can be associated with certain 
lifestyle factors. However, it was noted by Brenner et al. (2014) that no one of the risk 
factors is solely responsible for the majority of colorectal cancer diagnoses.   
There are modifiable and non-modifiable risk factors that can contribute to the 
development of colorectal cancer (Rawla, Sunkara, & Barsouk, 2019). Non-modifiable 
factors, such as age, gender, race, personal health history of inflammatory bowel 
disease, and heredity, are nothing any individual can change. Modifiable risk factors, 
however, are the behavioral and lifestyle factors which can be adjusted to reduce the 
risk of developing colon cancer and increase the chance of survival (Lee, Keum, & 
Giovannucci, 2016).  
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Risk increases with age and gender influences the probability of diagnosis. Kolligs 
(2016) indicated that more than half of initial cancer diagnoses are made after age 70 
and that men develop advanced cancer at twice the rate as and sooner in their lives 
than women while Favoriti et al. (2016) proposed that colorectal cancer prevalence 
increases considerably between the ages of 40 - 50 and in each 10-year period 
thereafter. Although age increases the risk of colorectal cancer, more individuals under 
45 years of age are receiving a colorectal cancer diagnosis and the incidence in this age 
group grew by 22% between the years 2000 and 2013 (Weinberg, Marshall, & Salem, 
2017). Kolligs (2016) pointed out that being male and having a close family member with 
colorectal cancer carries the same risk whereas Aran et al. (2016) suggested that the 
incidence in men is close to double than that in women.  
In a study that was reviewed by Connell, Mota, Braghiroli, and Hoff (2017), it was 
found that race or ethnicity influenced colorectal cancer incidence and that those who 
are white had lower rates than those who are black. Favoriti et al. (2016) suggested 
higher screening practices in those who are white because of differences in 
socioeconomic status. Correspondingly, biological differences include higher genetic 
predisposition at a younger age in those who are black and cancer occurrence mostly in 
the right and proximal transverse colon (Favoriti et al., 2016). This is significant to 
consider because cancers in that region of the colon are typically bigger in size (Baran et 
al., 2018). Siegel et al. (2017) claimed that the highest incidence and mortality rates 
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were in non-Hispanic blacks and noted that the lowest rates could be found in Asian 
Americans/Pacific Islanders. 
Individuals with inflammatory bowel diseases, such as Crohn’s disease or 
ulcerative colitis are also at increased risk for colorectal cancer due to chronic 
inflammation of the bowel (Barsouk, Rawla, Barsouk, & Thandra, 2019). Relatedly, 
Marley and Nan (2016) revealed that there is a correlation between inflammation 
associated with an ulcerative colitis diagnosis and time spent in active flare-ups and the 
development of colorectal cancer. In the same article, it was also noted that Crohn’s 
disease, although also an inflammatory condition, increases the risk but at a lower rate 
than ulcerative colitis. This was corroborated by Aran et al. (2016), who added that 
colorectal cancer develops via numerous interactive molecular pathways, which makes 
this type of cancer multifaceted and difficult to manage. Lastly, celiac disease, which is 
an auto-immune disorder that reacts with inflammation to the exposure of gluten in the 
gastrointestinal tract, can also increase the risk for development of colorectal cancer 
(Barsouk et al., 2019).  
A family history of colon cancer or even colon polyps represents another notable 
risk factor and makes up about one third of the risk, which increases as the number of 
biological relatives with a history increases and with the degree of the relative (Kolligs, 
2016). That means that a mother’s or father’s history or diagnosis increases the risk far 
more than an uncle’s or a cousin’s. Another crucial aspect to consider here is how old 
the relative was when he or she was first diagnosed because the risk for colon cancer 
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increased if the first-degree family member received their diagnosis at less than 50 
years of age (Connell, Mota, Braghiroli, & Hoff, 2017).  This will guide the age of first 
screening for the individual in question. Brenner et al. (2014) noted that genetic 
syndromes can also pose a risk but only make up less than 5% of colorectal cancer 
incidences and related details to that effect remain unclear.  
A correlation exists between the increased risk of developing colorectal cancer 
and a Westernized lifestyle, which entails certain dietary habits, diabetes, excessive 
alcohol and tobacco use, lack of weight management, and physical inactivity (Connell et 
al., 2017). The dietary habits include eating a high-fat, meat-based diet, insufficient 
amounts of dietary fiber intake from fruits, vegetables, and legumes (Turner & Lloyd, 
2017). In a study conducted by Young et al. (2019), the authors concluded that lifestyle 
factors alone as well as combined with inherited genetics increased colorectal cancer 
risk, and that genetics alone carried an equal amount of risk as lifestyle.  
Findings about how dietary practices increase the risk of colorectal cancer 
development vary between studies. Particular attention is paid to red and processed 
meat consumption (Turner & Lloyd, 2017). Santarelli, Pierre, and Corpet (2008) pointed 
out that consuming processed meat might be more detrimental than the consumption 
of red meat. Wilkins, McMechan, and Talukder (2018) noted that, although high fat 
consumption has also been found to increase the risk, there was not enough evidence in 
previous studies that adherence to a low-fat diet was cancer protective. Siegel et al. 
(2017) suggested that folic acid may have a contradictory influence on colorectal cancer 
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development in that it can be preventative of new growths, but also stimulate further 
advance of existing ones. Øines, Helsingen, Bretthauer, and Emilsson (2017) found a 
correlation between the presence of adenomas and unfavorable cholesterol levels at 
the time of the screening.  
Like dietary habits, body mass index (BMI) is a factor and important to consider. 
Øines et al. (2017) wrote that there is a small link between BMI and development of 
colorectal cancer. The authors noted that extra weight, as in overweight and obesity, 
can cause persistent low-grade inflammation, which can compound the risk for colon 
cancer.  Behaviors consistent with a high-fat and high-meat diet, coupled with sedentary 
lifestyle, result in rising numbers of overweight and obesity and influence cardiac health, 
blood sugar levels, metabolism, hormone balance, and immune system function (Young 
et al., 2019).  
Numerous studies connect an increased risk for cancer development with 
smoking habits. Aran et al. (2016) described tobacco smoke as containing over 7000 
chemicals, including known carcinogens. They also related colorectal cancer incidence 
and decreased survival with smoking. Øines et al. (2017) named smoking the number 
one modifiable risk factor for the development of polyps and colorectal cancer due to 
carcinogens which can cause permanent cigarette-specific genetic mutations inside of 
the colon. Cigarette smoke also causes inflammation (Young et al., 2019), which was 
mentioned earlier as one of the relatable causes for increase in risk. Bailie, Laughrey, 
and Coleman (2017) alluded to molecular mutations in smokers that constitute a 2.5 to 
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3.4-fold amplified risk for serrated or adenomatous polyps respectively. Hoffmeister, 
Jansen, Stock, Chang-Claude, and Brenner (2014) described the risk for colorectal cancer 
as being overcome by regular CRCS and polypectomy in those who were former 
smokers, but for those that continue to smoke into older age, the risk increases.  
Not unlike the increased risk presented by smoking, excessive alcohol 
consumption can escalate the danger for colorectal cancer development. Walter et al. 
(2016) cited the potentially fatal carcinogenic outcomes of alcohol metabolites and 
alcohol-related nutritional deficiencies and malabsorption. Wang, Duan, Yang, and Lin 
(2015) found that the more alcohol an individual consumes, the higher the risk for 
development of colorectal cancer becomes. Furthermore, the authors pointed out that 
alcohol consumption influences cancer death in general. Alcohol is also said to pose an 
enhanced risk in individuals with a first-line relative with a history of colorectal cancer 
(Rossi, Jahanzaib Anwar, Usman, Keshavarzian, & Bishehsari, 2018).  
Physical activity is a critical factor for the prevention of colorectal cancer, 
however not often mentioned separately in the literature. Rather, it is included in the 
list of risk factors and lifestyle behaviors such as diet and smoking but elaborated on 
more with prevention in mind. However, Santos Silva et al. (2018) reviewed a global 
longitudinal study and found a correlation between physical inactivity and disability-





Colorectal Cancer Screening Practices 
Colorectal cancer screening practices vary according to recommendations from 
assorted organizations like the American Academy of Family Physicians, the American 
Cancer Society, and U.S. Preventive Services Task Force but all have the following in 
common: for those of average risk, screening via colonoscopy should begin at 50 and 
end at 75 years of age unless risk factors, symptoms, personal or family history, or 
previous screening results determine otherwise and repeated every ten years while 
stool-based tests and flexible sigmoidoscopy are advised to be done more often 
(Wilkins, McMechan, & Talukder, 2018). In addition, Wilkins et al. (2018) documented 
that the recommended screening age decreases to 45 in African Americans per the 
American College of Gastroenterology and the U.S. Multi-Society Task Force on 
Colorectal Cancer, which was substantiated by Short, Layton, Teer, and Domagalsky 
(2015), who added that screening in African Americans should begin at age 45 since the 
colorectal cancer incidence in this population increases earlier. Colorectal cancer is a 
slow-growing cancer which can be prevented by regular screening and straightforward 
treatment if found early (Sorra, 2006). Screening and early intervention can, therefore, 
decrease mortality and cost. According to Short et al. (2015), 50-75 years of age is when 
routine screening should be performed on an individual of average risk, which is also 
noted by Wilkins et al. (2018), who listed various organizations and their screening 
recommendations.    
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Various options are available for screening. These options include both, stool-
based tests as well as structural exams. The stool-based exams are guaiac fecal occult 
blood tests (gFOBT) or fecal immunochemical tests (FIT), which uses antibodies to test 
for the presence of microscopic blood in the stool sample (Ahlquist, 2019). The benefits 
to these tests are that they can be done at home and are relatively easy and quick to 
perform. Ahlquist (2019) noted that screening with FIT every year not as helpful in the 
detection of colorectal cancer as multitarget DNA stool-based tests or colonoscopies. 
However, the author also interjected that FITs are more sensitive in detecting advanced 
adenomas and cancer than gFOBTs (Ahlquist, 2019).     
Structural exams, such as sigmoidoscopy and colonoscopy, are done by use of 
flexible tubes equipped with a camera on the end, which allows direct visualization of 
the inside of the colon wall; partially in a sigmoidoscopy, and completely during a 
colonoscopy. Abdel-Rahman and Cheung (2019) advised that sigmoidoscopies should be 
performed every 10 years, just like regular screening colonoscopies can be done every 
10 years. During either procedure, polyps can be identified, removed, and tested.  
In a study conducted by Hol et al. (2010), the authors found that flexible 
sigmoidoscopy and colonoscopy were the preferred methods over stool-based 
approaches for CRCS in patients who had previous screening, as well as those who had 
never been screened before. Hoffman, Teubner, and Kiesslich (2014) called colonoscopy 
the definite gold standard screening method for colorectal cancer. Ahlquist 
acknowledged that the inside colon wall can be fully visualized and any polyps removed 
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at the same time. It was also noted that the precision in adenoma detection during a 
colonoscopy relies on the expertise and awareness of the proceduralist (Ahlquist, 2019).   
Other screening tests are available. Among those are double-contrast barium 
enemas, computed tomographic (CT) colonography or virtual colonoscopy, and capsule 
colonoscopy, which are not as frequently used (Wilkins et al., 2018).  
Screening Barriers 
 Not everyone eligible for colorectal cancer screening participates when they 
reach the recommended age. Bromley, May, Federer, Spiegel, and Van Oijen (2015) 
remarked that while African Americans constitute the ethnic group with the greatest 
number of colorectal cancer diagnoses and death rates, they are also the group least 
likely to present for an exam. The authors cited fear, lack of knowledge about the risks, 
benefits, and screening procedure itself, lack of physician recommendation, and 
financial difficulties among the top barriers for this subgroup to undergo colorectal 
cancer screening. Barriers not only exist based on race or ethnicity but also because of 
level of education, income, and insurance status (Redmond Knight, et al., 2015). 
Attitudes and beliefs are barriers for more affluent and educated white adults, while 
cost was the most predominant barrier in less educated, low-income black adults 
(Redmond Knight et al., 2015).  
Sahin, Aker, and Arslan (2017) noted fear of bad test results as the number one 
barrier to receive colorectal cancer screening, followed by being embarrassed of the 
test, and the screening potentially being painful and uncomfortable as the main reasons 
22 
 
not to get screened. Cossu, Saba, Minerba, and Mascalchi (2018) pointed out that a lack 
of knowledge concerning the screening process could lead to fear and anxiety about 
what screening results would show and whether there would be discomfort or unease 
during the procedure. Other barriers that were described included readiness, being too 
busy, fear about the test, lack of conversation about screening with healthcare provider, 
lack of insurance, insufficient time, no intentions to get screened, and a general distaste 
towards screening (Ely, Levy, Daly, & Xu, 2016).  
Similar findings come up in other articles. However, Katz, Young, Zimmermann, 
Tatum, and Paskett (2018) noted that their results showed the test as not being a 
priority or even an inconvenience as the most frequent answer, closely followed by the 
belief that there is no family history of colorectal cancer, and therefore no need for 
screening. Hasan et al. (2017) discovered that the majority of study participants would 
have a colonoscopy screening if their doctor told them to and that they just don’t know 
enough about colorectal cancer to make an informed decision.  
Importance of Screening and Prevention 
Early screening and prevention will reduce colorectal cancer related morbidity, 
mortality, and healthcare cost. Using findings from current research and following the 
best practices available can avert a cancer diagnosis for those with one or more risk 
factors (Short et al., 2015). Apart from regular and timely screening and lifestyle 
modifications, prevention measures include assessment of personal risk related to 
genetics and heredity (Kolligs, 2016), consumption of fish and fish oil, a high intake of 
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fiber, calcium, and vitamin D, and regular exercise (Marley & Nan, 2016). Of particular 
interest was the fact that there can be a 20%-25% reduction in colorectal cancer risk 
with physical activity (Santos Silva, et al., 2018). Conflicting information is found about 
the daily use of aspirin as a preventive measure due to the danger of developing 
bleeding in the gastrointestinal system (Gravitz, 2015). Since the risks outweigh the 
benefits, aspirin is worth mentioning, but deserves caution.   
Gender-specific Differences in Attitudes Toward Colorectal Cancer 
McKinney and Palmer (2014) discussed how gender affects knowledge of and 
worry about colorectal cancer, perceived risk of being diagnosed with the disease, and 
CRCS intention. The findings suggested that there is no difference in how much men 
worried about CRCS versus the level of worry in women and they also did not find a 
difference in intention to receive CRCS. There was, however, a discrepancy in 
knowledge, perceived risk, and understanding of colorectal cancer but this study was 
only focused on African Americans in Florida.  (McKinney & Palmer, 2014). In a study 
conducted by White et al. (2018), it was observed that women had higher CRCS rates 
than men although those results only included answers from participants aged 60-74. 
Ritvo et al. (2013) learned that women were uncomfortable with the thought of how a 
colonoscopy is performed, embarrassed about CRCS, and had a fear of colonic 
perforation, while men displayed an avoidant attitude of procrastination, thought that 
CRCS was unnecessary healthcare, and felt vulnerable. Other points mentioned were a 
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better relationship between providers and women, more knowledge about colorectal 
cancer in women, and greater emotional distance in regards to choosing CRCS in men.  
Summary 
Colorectal cancer, or cancer of the colon or rectum, is the third most common 
and deadly cancer in the United States and ranks in the top five for leading cause of 
cancer death around the world. Lifestyle choices, specifically modification of risk factors, 
such as smoking, eating an unhealthy diet full of meat and fat and devoid of fruits, 
vegetables, and dietary fiber, physical inactivity, and excessive alcohol consumption can 
influence the risk for development of colorectal cancer. Treatment options depend on 
staging. Colorectal cancer can be screened for by various methods, but the most 
common are stool-based and direct visualization tests. Barriers to screening are 
abundant. The most frequently named are fear of the test or what the results could be, 
attitudes regarding perceived susceptibility, and cost. Timely and individualized 
screening as well as a number of preventive measures can lead to early detection and 
easier treatment as well as better health outcomes and decreased mortality. Limited 
information is available about specifics regarding gender-related differences in attitudes 










The purpose of this study was to assess the extent to which participants received 
their primary CRCS by the recommended age and barriers that prevented timely CRCS. 
Furthermore, this study was conducted to evaluate the difference in the specific barriers 
to timely initial CRSC for men compared to women. This chapter describes the research 
design, sample selection and technique, data collection procedures, instrumentation, 
validity and reliability of the instrument, and data analysis.  
Research Questions 
 This study addressed the following research questions:  
1. What are the colorectal cancer screening practices among males and females 
ages 45-55? 
2. What potential barriers exist that prevent individuals from undergoing timely 
colorectal cancer screening? 
3. What are the knowledge levels of colorectal cancer screening among those who 
have an have not received screening? 
Research Design  
A descriptive, cross-sectional, survey-based design was used for this study. 
Descriptive data was used explain what happened in the sample by summarizing it using 
measures of central tendency and dispersion (Thompson, 2009). A descriptive research 
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design uses observation of a behavior or situation as it occurs naturally, without the 
researcher’s interference or manipulation of variables (Kim, Sefcik, & Bradway, 2017). It 
is helpful to use a descriptive design when an experiment is not practical, for instance 
with limitations of time and budget to conduct the study, as was the case for the current 
study. The cross-sectional study design was used because it assesses the variables at 
one point in time and is largely used for population-based surveys (Setia, 2016). A cross-
sectional design is intended to provide estimates of the pervasiveness of a certain 
illness, including attitudes and behaviors (Kesmodel, 2018). The time to conduct this 
study was limited to three weeks and a cross-sectional design was therefore more 
appropriate than a design that would require more time. Surveys make it possible to 
sample a sizeable number of participants from a chosen population (Safdar, Abbo, 
Knobloch, & Seo, 2016).  
Sample Selection 
This study was comprised of a convenience sample of men and women between 
the ages of 45 and 55 years old, which is the newest recommended age at which to start 
CRCS (American Cancer Society, 2020). Data collection took place during the spring 
semester of 2020.  
Convenience sampling was the sampling technique chosen for this study. 
Convenience or opportunity sampling is the most customary when no other conditions 
need to be met apart from the convenience of the person or persons conducting the 
research (Farrokhi & Mahmoudi-Hamidabad, 2012). Using this type of sampling allows 
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the researcher to utilize the part of a population that is close at hand and requires very 
little resources (Hedt & Pagano, 2011). Convenience or opportunity sampling is used 
most often because it saves time and money. The current study was limited in time to 
only a small portion of the spring semester 2020 and there was a limited budget. A 
geographical area from which participants are selected was not defined for this study 
and no identification of geographical location was requested in the demographics.  
Data Collection Procedures 
The researcher contacted various individuals from organizations like Lifetime 
Fitness Corporate, Minnesota Public Health Association, Sons of the American Legion, 
and Minnesota Society for Public Health Education by email to inquire about them being 
able and willing to distribute via email an introduction, purpose of the study, and the 
survey link within their respective organizations. These individuals agreed and 
distributed the online survey link along with the above-mentioned information to their 
specific email lists with the request for the survey to be completed at the participants’ 
convenience. Additionally, postcards with the same information as noted above were 
printed and left at the front desk of two locations of a local gastroenterology clinic. 
Permission for this distribution was extended verbally as well as in writing to the 
researcher. The cards were left at the two clinic sites with a request for them to be 
distributed to those patients who met the inclusion criteria. Lastly, the link and 
accompanying information were shared on social media by persons known to the 
researcher as well as on city-specific social media sites, along with requests to also share 
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the link to recruit further participants. The survey was conducted only by means of the 
Qualtrics® web-based survey software and no paper copies were distributed.  
Krejcie and Morgan (1970) developed a formula and a corresponding table for 
determining research sample size needed to be representative of a given population. 
According to that table, an estimated number of 384 participants were necessary to 
ascertain the data needed for this survey to be representative of the study population 
and to establish statistically meaningful and significant results. Having statistically 
significant and meaningful results suggests that those results did not happen by chance.   
Inclusion criteria for this study consisted of being male or female, 45 to 55 years 
old, and having had or planning to have an initial colonoscopy for the purpose of 
colorectal cancer screening. Exclusion criteria were being of an age that is outside of the 
given age range and not answering any questions.  
Instrumentation 
Select items and questions from the National Cancer Institute’s Health 
Information National Trends Survey 2003 (HINTS, 2003) were used to assess screening 
practices, barriers to receiving CRCS, and knowledge about colorectal cancer (National 
Cancer Institute, 2018). The HINTS 2003 survey instrument is available online in its 
entirety and permission to use items was granted via personal email from the National 
Institute of Health to the researcher. The items for the current study were used to 
create a survey utilizing the Qualtrics® web-based software, which will collect survey 
results.   
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The year 2003 was the first year during which the HINTS was conducted by the 
National Cancer Institute (NCI) to research “the American public’s knowledge of, 
attitudes toward, and use of cancer- and health-related information” (National Cancer 
Institute, 2018, para. 1). The instrument is a  survey originally designed to be delivered 
via telephone and comprised of 14 separate sections to include household details, 
health communication, cancer history and knowledge, specific cancers like colon, 
breast, cervical, and prostate, and health-related behaviors like tobacco use, fruit and 
vegetable intake, and exercise, overweight and obesity, general health status, and, 
lastly, demographics. Each section has varying numbers of questions, ranging from 2 to 
33. The types of questions in the HINTS 2003 vary. Some questions are multiple 
choice/pick all that apply, some yes or no, and some are Likert-type. 
As there are sections in the HINTS 2003 that were not applicable to this study, 
particularly those related to other types of cancer and health-related behavior, only 
those items associated with colorectal cancer were chosen to be included. Necessary 
demographic items in the present study were limited to age, gender, race, and ethnicity. 
Other demographic items were omitted. Items that were included from HINTS 2003 
originated from the colon cancer section and included three Likert-type questions 
related to perceived personal risk, 23 items related to screening knowledge and 
behaviors in various formats and addressing colonoscopies as well as stool-based 
screening tests, and two questions about detection and curability of colon cancer. Items 
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CC-9, CC-11, CC-12 were omitted because they did not address any of the current study 
variables.  
Since the following questions were not addressed in the HINTS 2003 survey, they 
were added to address research questions and variables to be measured. Apart from 
question #1, they will be given a Likert-type response:  
1. At what age did you have your first screening colonoscopy?  
2. Did the colonoscopy prep bother you? 
3. Were you fearful of the results? 
4. Were you fearful of the test itself? 
5. How easy was it to take off from work to have screening done? 
All questions in the current study were numbered consecutively.   
Descriptive information was gathered from the survey, which explored the 
participants’ CRCS practices, the age at which screening first occurred, and any reasons 
for the delay of screening. Moreover, the potential barriers to receiving timely CRCS 
were established and the difference in these barriers between men and women were 
uncovered.  
Validity and Reliability 
 Minimal information was available regarding validity and reliability of this 
national survey instrument, even though survey items were used in numerous articles 
(National Cancer Institute, n.d.). Nelson et al. (2004) noted that “scientific validity 
criteria emphasized including items that have been demonstrated to measure 
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population-based constructs in reliable ways” (p. 447). The validity elements mentioned 
by Nelson et al. (2004) included that self-reported information can provide valid 
assessments for the adult population, and well-established measures of cancer-related 
information or knowledge. Schnittker and Bacak (2014) remarked that the validity of a 
self-reported health assessment such as HINTS 2003 is also greatly influenced by 
knowledge levels of health-related issues and an increased use of technology to obtain 
such knowledge. Ok, Marks, and Allegrante (2008) pointed out that the HINTS 2003 
survey was created by “using constructs from established health communication and 
behavior change models” (p. 640).  
Reliability was only mentioned regarding the five communication item responses 
in the study done by Ok, Marks, and Allegrante (2008), indicating that the results for all 
of them were similar. Finney Rutten et al. (2019) reported that data quality was assured 
by first conducting cognitive testing of new survey items in each HINTS instrument. This 
was noted to grant valid measures of the constructs in question as well as minimal 
inaccuracy in responses. Furthermore, Finney Rutten et al. (2019) related that, in 
comparison with validated multi-item scales, “single-item measures can have similar 
test–retest reliability and construct validity” (p. 8).   
Data Analysis  
 Data analysis was conducted using the IBM Statistical Package for Social Sciences 
(IBM SPSS® Statistics 26). Descriptive statistics, including frequencies, percentages, and 
means, were calculated to describe data, a Mann-Whitney test was performed and an 
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alpha level of .05 selected to assess differences in CRCS between males and females 
(Table 1).  
Table 1 
Table of Specifications 
 
2. What potential 
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Data will be collected from items from the National Cancer Institute’s HINTS 
2003 survey instrument in addition to several added questions, addressing the study 
variables and research questions. Sampling will be conducted using cluster and snowball 
sampling and data will be collected via mixed methods. Data analysis will be performed 
using IBM SPSS® and descriptive statistics as well as independent samples t-test used to 




















The purpose of this study was to assess the extent to which participants received 
their primary colorectal cancer screening by the recommended age and any barriers 
that prevented participants from receiving timely colorectal cancer screening. 
Furthermore, the researcher sought to evaluate differences in barriers to timely initial 
colorectal cancer screening for men compared to women. This chapter gives an 
overview of the results of the study.  
A total of 316 surveys were collected via Qualtrics® web-based survey software 
from potential participants and 161 surveys (51%) were used for data analysis. The 
remainder of the surveys (49%, n = 155) were rejected due to incomplete/missing data 
(more than 5%) or the participants’ age outside of the required range of 45-55 years.  
Demographics of the Sample 
The sample consisted of 161 adults between the age of 45-55 years of age. 
Participants were primarily female (82%), non-Hispanic (96.9%), and Caucasian/White 









Item                                                          n(%)            Item                                       n(%) 
  
Sex* Age 
Male      28(17.4)        45 Years      12(7.5) 
Female   132(82) 46 Years      11(6.8) 
Race* 47 Years      15(9.3)  
Caucasian/White    152(94.4) 48 Years    24(14.9) 
African American/Black          1(0.6) 49 Years      13(8.1) 
Asian          2(1.2) 50 Years    18(11.2) 
Other          2(1.2) 51 Years      12(7.5) 
Two or more races          3(1.9) 52 Years      11(6.8) 
Ethnicity* 53 Years      12(7.5) 
Hispanic          3(1.9) 54 Years      13(8.1) 
Non-Hispanic   156(96.9) 55 Years    20(12.4) 
  
  
Note. *Totals not equaling 100% indicates missing data. 
 
Assessment of Research Questions 
What are the colorectal cancer screening practices among males and females 
ages 45-55? 
Out of the sample of 161 participants, 151 (93.8%) have never had a 
sigmoidoscopy, 73 (45.3%) have never had a colonoscopy, 71 (44.1%) have not had 
either, and 144 (89.4%) have never done a home stool blood test. Seventeen 
participants (10.6%) have used a home stool blood test kit. Among those who have used 
a home stool blood test kit, seven (4.3%) used a home stool blood test kit less than a 
year ago, four (2.5%) used a home stool blood test kit more than a year but no more 
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than two years ago, one (0.6%) used a home stool blood test kit more than two years 
but not more than five years ago, and five (3.1%) used a home blood test kit more than 
five years ago. For reasons that were not specified in the study, 33 (20.5%) participants 
had their first screening colonoscopy before the age of 45. A total of 22 (13.7%) 
participants were screened between 45 and 49 years of age, 26 (16.1%) had their first 
screening when they were 50 or 51 years old, seven (4.3%) at age 52 or 53, and one 
participant (0.6%) could not remember when she had her first screening. Ninety 
participants (55.9%) have received CRCS via sigmoidoscopy or colonoscopy. Among 
those participants, 32 (19.9%) Received CRCS within the past year, 44 (27.3%) more than 
a year but not more than five years ago, 10 (6.2%) more than five but less than 10 years 
ago, and four (2.5%) had their last screening more than 10 years ago. Fifty-two 
participants (32.3%) have only had one CRCS, while 37 participants (23%) have had more 
than one. Out of those 37 participants, five (3.1%) reported having had CRCS within the 
past year, 17 (10.6%) between one and five years, 11 (6.8%) between five and 10 years, 
and four (2.5%) more than 10 years between CRCS (Table 3).  
Table 3 
Participants’ Screening Practices 
 
Item                                                                                                                                n(%) 
 
1. Have you ever had a sigmoidoscopy? 
 Yes                                                                                                                10(6.2) 




Table 3 continued 
 
 
Item                                                                                                                                n(%)  
 
2. Have you ever had a colonoscopy? 
 Yes                                                                                                              88(54.7) 
 No                                                                                                               73(45.3) 
3. Age at first CRCS  
 Not yet                                                                                                       72(44.7) 
 Before 45                                                                                                   33(20.5) 
 45-49                                                                                                          22(13.7)   
 50-51                                                                                                          26(16.1) 
 52-53                                                                                                             7(4.3) 
 Can’t remember                                                                                            1(0.6) 
4. Most recent stool blood test 
 Never                                                                                                        144(89.4) 
 A year ago or less                                                                                          7(4.5) 
 Between 1 and 2 years ago                                                                         4(2.6) 
             Between 2 and 5 years ago                                                                         1(0.6) 
 More than 5 years ago                                                                                 5(3.1) 
5. Most recent sigmoidoscopy/colonoscopy 
 A year ago or less                                                                                     32(19.9) 
  More than 1 but no more than 5 years ago                                        44(27.3) 
             More than 5 but no more than 10 years ago                                        10(6.2) 
             Over 10 years                                                                                                4(2.5) 
             I have never had either                                                                           71(44.1) 
6. how many years since previous CRCS?* 
 A year ago or less                                                                                         5(3.1) 
             More than 1 but no more than 5 years ago                                        17(10.6) 
             More than 5 but no more than 10 years ago                                        11(6.8) 
             Over 10 years                                                                                                4(2.5) 
             I have only had one CRCS                                                                       52(32.3) 
             I have never had a sigmoidoscopy/colonoscopy                               71(44.1) 
 
 
Note. *Totals not equaling n = 161(100%) indicates missing data   




What potential barriers exist that prevent individuals from undergoing timely 
colorectal cancer screening? 
Not every participant answered items in this portion of the survey, which left 
anywhere from 26.1% to 71.4% of missing data (Table 4). Of those that did answer, 12 
participants (7.5%) said that ‘didn’t know I needed this test’ was a major barrier and 10 
(6.2%) called it a moderate barrier. CRCS being too expensive or the participant not 
having insurance was a major barrier to 11 (6.8%) and a moderate barrier to nine (5.6%) 
participants. Close to a quarter of participants (n = 38, 23.6%) also said that they put it 
off or didn’t get around to it, with 11 (6.8%), 14 (8.7%), and 13 (8.1%) choosing this 
respectively for major, moderate, or minimal barrier.   
The greatest reported major barrier to receiving CRCS among the participants 
was that the they did not have a doctor’s order or they were not told by their doctor 
that they needed it (n = 23, 14.3%), while 12 participants (7.5%) called it a moderate 
barrier. This is equally followed by the test being too painful, unpleasant, or 
embarrassing as a major (n = 17, 10.6%) or moderate (n = 19, 11.8%) barrier and not 
having had any problems or symptoms as a major (n = 17, 10.6%) or moderate (n = 10, 
6.2%) barrier. Within the eligible age range, 15 participants (9.3%) ranked their age or 
thought that they were too young as a major and 10 (6.2%) as a moderate barrier.   
One notable finding was that a total of 63 participants (54.8%) reported the prep 
for CRCS presented some type of barrier with 15 (9.3%)saying it was a major, 27 (16.8%) 
saying it was moderate, and 21 (13%) saying it was a minimal barrier. Fifty-six 
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participants (47.9%), found the test too painful, unpleasant, or embarrassing, rating it a 
major (n = 17, 10.6%), moderate (n = 19, 11.8%), barrier (Table 4). Lastly, fear also 
generated obstacles for CRCS. Ten participants each (6.2%) conveyed major fear of the 
test as well as the results while 13 participants (8.1%) were moderately fearful of the 
test versus eight (5%) who were moderately fearful of the result. Specific comments in 
this section included that arranging a driver meant that another person had to take off 
work, the negative side of undergoing the prep, and a general dislike for doctors. 
Table 4 






























2. Didn’t need it 9(5.6) 6(3.7) 11(6.8) 91(56.5) 117(72.7) 
3. Didn’t know I needed  
     this test 
12(7.5) 10(6.2) 8(5) 87(54) 117(72.7) 
4. Doctor didn’t order  
     it/didn’t say I needed it  
23(14.3) 12(7.5) 12(7.5) 71(44.1) 118(73.3) 
5. Haven’t had any  
     problems/no symptoms 
17(10.6) 10(6.2) 16(9.9) 72(44.7) 115(71.4) 
6. Put it off/didn’t get  
around to it 
11(6.8) 14(8.7) 13(8.1) 79(49.1) 117(72.7) 
7. Too expensive/no  
     insurance 
11(6.8) 9(5.6) 15(9.3) 83(51.6) 118(73.3) 
8. Too painful, unpleasant,  
     or embarrassing 
17(10.6) 19(11.8) 20(12.4) 61(37.9) 117(72.7) 
9. Had another type of  
     colon exam 
1(0.6) 2(1.2) 4(2.5) 106(65.8) 113(70.2) 
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11. Never heard of  
       it/never thought about  
       it 
3(1.9) 3(1.9) 8(5) 95(59) 109(67.7) 
12. Age/thought they were  
       too young 
 15(9.3) 10(6.2) 13(8.1) 76(47.2) 114(70.8) 
13. Preparing for the  
       colonoscopy bothers  
       me 
15(9.3) 27(16.8) 21(13) 52(32.3) 115(71.4) 
14. I am fearful of the test 10(6.2) 13(8.1) 20(12.4) 71(44.1) 114(70.8) 
15. I am fearful of the  
       results 
10(6.2) 8(5) 17(10.6) 78(48.4) 113(70.2) 
16. Could not get time off  
       from work 
3(1.9) 6(3.7) 13(8.1) 92(57.1) 114(70.8) 
17. Other 3(1.9) 1(0.6) 0(0) 42(26.1) 46(26.6) 
 
Note. *Totals not equaling n = 161(100%) indicates missing data   
 ͣSurvey items/Questions were adapted from National Cancer Institute (2003) 
 
The results of the Mann-Whitney tests showed that males considered the 
following attitudes as a lesser barrier than women or women saw greater obstacles in 
the following: ‘no specific reason’ (U = 1013.5, z = -2.181, p = .029); ‘didn’t need it’ (U = 
834, z = -3.097, p = 0.002); ‘didn’t know I needed this test’ (U = 888, z = -2.459, p = 
0.014); ‘too expensive/no insurance’ (U = 921, z = -2.147, p = 0.032); ‘had another type 
of colon exam’ (U = 985, z = -2.185, p = 0.029); ‘never heard of it/never thought about it’ 
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(U = 816, z = -2.078, p = 0.038) ‘I am fearful of the results’ (U = 816, z = -2.566, p = 0.010) 
(Table 5). 
Table 5 
Mann-Whitney Test Results 







       
No specific reason Male 26 52.48 1013.50 -2.181 p<.05 
Female 92 61.48 
Didn't need it Male 26 45.58 834.00 -3.097 p<.05 
Female 90 62.23 
Didn't know I needed this 
test 
Male 26 47.65 888.00 -2.459 p<.05 
Female 90 61.63 
Doctor didn’t order it/didn’t 
say I needed it 
Male 25 49.38 909.50 -1.825 p>.05 
Female 92 61.61 
Haven’t had any 
problems/no symptoms 
Male 26 53.88 1050.00 -.737 p>.05 
Female 88 58.57 
Put it off/didn’t get around 
to it 
Male 26 55.27 1086.00 -.674 p>.05 
Female 90 59.43 
Too expensive/no insurance Male 26 48.92 921.00 -2.147 p<.05 
Female 91 61.88 
Too painful, unpleasant, or 
embarrassing 
Male 25 67.12 922.00 -1.576 p>.05 
Female 91 56.13 
Had another type of colon 
exam 
Male 26 51.38 985.00 -2.185 p<.05 
Female 86 58.05 
Don’t have doctor Male 26 52.33 1009.50 -1.345 p>.05 
Female 86 57.76 
Never heard of it/never 
thought about it 
Male 23 47.48 816.00 -2.078 p<.05 
Female 85 56.40 
Age/thought they were too 
young 
Male 26 51.48 987.5 -1.177 p>.05 
Female 87 58.65 
Preparing for the 
colonoscopy bothers me 
Male 26 57.56 1142.50 -.011 p>.05 
Female 88 57.48 
I am fearful of the test Male 26 55.00 1079.00 -.441 p>.05 
Female 87 57.60 
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Table 5 continued 







       
I am fearful of the results Male 26 44.88 816.00 -2.566 p<.05 
Female 86 60.01 
Could not get time off from 
work 
Male 26 52.81 1022.00 -1.098 p>.05 
Female 87 58.25 
Other Male 9 25.50    
Female 37 23.01 
       
 
Note. *Totals not equaling n = 161 indicates missing data. 
 ͣSurvey items/Questions were adapted from National Cancer Institute (2003) 
 
What are the knowledge levels of colorectal cancer screening among those 
who have and have not received screening? 
The results revealed a mean knowledge score of 2.37 (SD = 1.12) with possible 
scores ranging from 0-6. When asked what participants knew about colorectal cancer 
screening, roughly half (n = 80, 49.7%) were able to correctly identify the tests used for 
detection of colorectal cancer. Ninety-two participants (57.1%) knew at what age people 
are supposed to perform home stool blood tests, but only 54 participants (33.5%) knew 
the frequency at which the stool blood test should be performed. Just over 75% (n = 
122) of participants identified the age at which people are supposed to have 
sigmoidoscopy or colonoscopy exams correctly. Yet, only 10 participants (6.2%) knew at 














   
Which of the following tests can detect colorectal cancer? 80(49.7) 81(50.3) 





In general, once people start doing home stool blood tests, 
about how often should they do them? 
54(33.5) 107(66.5) 
At what age are people supposed to start having 
sigmoidoscopy or colonoscopy exams? 
122(75.8) 39(24.2) 
In general, once people start having sigmoidoscopy exams, 
about how often should they have them? 
24(14.9) 137(85.1) 
In general, once people start having colonoscopy exams, 
about how often should they have them? 
10(6.2) 151(93.8) 
   
 
ͣSurvey items/Questions were adapted from National Cancer Institute (2003) 
 
Summary  
A total of 161 usable surveys were utilized for analysis. The sample was made up 
of mostly non-Hispanic Caucasian/white females, evenly distributed across the age 
range in question. The greater part of participants has never had a sigmoidoscopy or 
performed a home stool blood test and just over half of them reported having had a 
colonoscopy. A significant number of participants started CRCS before the generally 
recommended age of 50. More than half of the participants reported not having any 
other barriers to CRCS than those listed in the survey. Lack of an order from a healthcare 
provider or being told that CRCS was needed was cited as the greatest barrier to 
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receiving CRCS among the participants while not having a doctor and having had 
another colon exam was cited as the least. Close to half of the participants established 
that the prep was a barrier and too painful, unpleasant, or embarrassing. Overall, the 
results showed that all the mentioned barriers were greater for women than they were 
for men. Approximately half of participants were knowledgeable about which test 
would identify colorectal cancer, slightly more were aware of the age at which home 
stool blood testing starts, and about three quarters of participants knew when to start 
endoscopic CRCS. Knowledge of frequency of either stool-based tests or CRCS via 
















Interpretation of Findings 
Introduction 
The purpose of this study was to assess the extent to which participants received 
their primary colorectal cancer screening by the generally recommended age and any 
barriers that prevented participants from receiving timely colorectal cancer screening. 
Moreover, the researcher sought to evaluate the difference in barriers for timely initial 
colorectal cancer screening for men compared to women.   
This research focused on establishing CRCS practices of individuals aged 45-55 
years old, their potential barriers towards CRCS, and participants’ knowledge levels 
surrounding CRCS. An interpretation and explanation of the research questions and 
findings, discussion, and recommendations are included in this chapter.  
Overview 
The findings indicate that non-Hispanic, Caucasian/White, and female 
participants were the most prevalent respondents to participate in the survey. Since the 
general population of the United States is not just made up of non-Hispanic, 
Caucasian/White, females but rather a much more diverse group of people, the results 
of this survey are skewed towards only a small portion of the general population and do 
not give an adequate representation of the population as a whole. Ages of participants 
ranged from 20 to 78 years. However, those outside of the desired age range were 
eliminated from the sample.   
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Sigmoidoscopy and home stool blood tests were the two screening modalities 
with which the participants had the least experience. Additionally, nearly half of 
participants have not had any CRCS at all. There was no option to specify possible 
reasons why a participant may have had CRCS before the age of 45. However, out of 
those participants who have had a colonoscopy, over a third of participants reported 
that they started screening before the generally recommended age of 50, which 
correlates with over two-thirds of participants having had more than one colonoscopy 
already. The number of those that have waited more than ten years in between 
colonoscopy screenings was small.  
In regards to barriers, colon exams other than those focused on in the present 
study, like barium enemas, lower GI series, CT colonography, or capsule colonoscopy 
were not mentioned as much of a barrier by most participants either, because these 
tests are not commonly done for CRCS. Not having a doctor was only reported as a slight 
obstacle to receiving CRCS. Conversely, not having a doctor’s order or their doctor not 
mentioning the need for CRCS, the test being too painful, unpleasant, or embarrassing; 
and not having any problems or symptoms of colon cancer were named as the leading 
obstacles.  
More than half of the participants reported that the test prep presented some 
sort of barrier and comments were made that ‘the prep is awful,’ ‘the prep is horrible,’ 
and ‘I have seen what prep does to people when I often pick them up in the early 
morning hours for severe dehydration, weakness and altered mental status.’ Other 
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comments suggested having to find a responsible person/driver means that another 
person must take time off work, presenting an imposition to more than just the patient, 
and a general dislike for doctors also could pose as a barrier.  
When conducting comparisons between the barriers of males versus females, all 
statistically significant comparisons showed a greater barrier for females than for males. 
Those items include ‘no specific reason,’ ‘didn’t need it,’ ‘didn’t know I needed this test,’ 
‘too expensive/no insurance,’ ‘had another type of colon exam,’ ‘never heard of it/never 
thought about it,’ and ‘I am fearful of the results.’  
Knowledge levels were varied. Almost half of the participants were able to 
correctly identify the tests used for detection of colorectal cancer. Over half correctly 
identified the general age at which CRCS via home stool blood tests is supposed to start, 
but only a third knew at what frequency they should be performed. Similar results were 
seen with the identification of starting age and frequency for 
sigmoidoscopy/colonoscopy. Three quarters of participants knew the general 
recommended age but less than 10% of participants correctly named the frequency.  
Discussion 
This study revealed some important findings. Colonoscopies were the most 
frequently reported CRCS test in this sample. Sovich, Sartor, and Misra (2015) pointed 
out that “colonoscopy is the gold standard for CRC screening and the most common 
method in the United States” (p. 1) and that approximately two-thirds of adults over 50 
in the United States follow CRCS recommendations from the United States Preventive 
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Services Task Force. The average age of participants was just over 50 years old (M = 
50.07, SD = 3.153) with 93 (57.8%) of them 50 years of age and under and more than 
half of them (n = 83, 53.9%) reported having had at least one colonoscopy. Considering 
that the general recommendation is to do CRCS from 50-75 years of age, which is likely 
the age range Sovich, Sartor, and Misra (2015) used to report their findings since there 
was no age limitation noted in the article, it is encouraging to see that the present 
sample is ahead of the curve.   
Salimzadeh, Delavari, Montazeri, and Mirzazadeh (2012) found that “four 
commonly cited reasons for not having CRC tests were “doctor did not recommend the 
test,” “did not think it was needed,” “never think of the test,” and “no 
symptoms/problems” which were reported by 29%, 26%, 20%, and 17% of the 
participants, respectively” (p. 29). Hughes, Watanabe-Galloway, Schell, and Soliman, 
(2015) identified the cost of CRCS and lack of insurance, feelings of embarrassment, lack 
of knowledge of benefits of CRCS, and access to care as barriers to receiving CRCS. 
Within the sample of this study, the most prevalent barriers to receiving CRCS were 
found to be no physician order or discussion that the test is needed, a lack of signs or 
symptoms of colorectal cancer, and the test itself creating emotional and physical 
discomfort. Many participants also designated the prep as appalling. Therefore, the 
outcomes of this study are consistent with previous findings.  
Another similarity this study revealed to the existing literature was that there is a 
general knowledge deficit of the screening process, which leads to anxiety over mental 
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and physical discomfort during the exam as well as potentially detrimental test results. 
Hasan et al. (2017) reported that a general knowledge deficit about colorectal cancer 
prevented patients from making an informed decision whether to receive CRCS. 
Salimzadeh et al. (2016) also determined that there was a strong knowledge deficit in 
regards to both, colorectal cancer, and CRCS practices.  
Overall, the current study showed that the perception of barriers was higher in 
women than in men. Wong et al. (2013) described the same phenomenon. Their 
findings stated that more women chose all of the following categories as a greater 
barrier than men did: preference of not knowing about a positive cancer diagnosis, fear 
of finding out that they have colorectal cancer, cost of the screening, potentially 
dangerous side effects of colonoscopies, painful tests, embarrassment of having a 
colonoscopy performed, and inconvenience of CRCS. These results match what the 
current study found when making the contrast between barriers for men compared to 
those for women.  
A larger sample that is more representative of the general population in this 
country may have resulted in different outcomes, but it is encouraging to see that this 
sample shows screening numbers that are in line with the recommendations, especially 
considering that the age group chosen for this study encompasses only the lower end of 
the recommended screening ages. Prevention happens when people get timely 
screening. Therefore, the facts that such a large portion of the sample have already had 
multiple screenings, evidenced by reporting time between previous and most recent 
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screening, and that one participant even specified getting screened every time the 
doctor recommended it, are reassuring that barriers are not keeping patients from 
following CRCS recommendation.  
Recommendations for Healthcare Providers 
A large portion of the participants viewed the lack of doctor’s order or 
encouragement for a colonoscopy from their primary care provider as a major barrier to 
receiving CRCS. Healthcare providers therefore need to add CRCS to the list of regular 
screening procedures, like mammograms or blood tests for prostate cancer. Education 
can be done during annual wellness visits or check-ups with the provider. The American 
College of Gastroenterology (ACG, n.d.) offers a colorectal cancer community education 
toolkit which includes online links where patients can explore information by 
themselves, slides containing pertinent information in easy-to-understand language, 
brochures to hand out and posters to hang on the clinic office walls, as well as podcasts 
and videos. These resources are ready and easy to use. Since women seem to be more 
hesitant in receiving CRCS, gender-specific education, which is available from the ACG, is 
appropriate to use when talking to one sex over the other.  
However, more detailed information about the medical and clinical aspects of 
colorectal cancer and CRCS can always be gathered from sites like the CDC, ACS, and 
major healthcare facilities. It is highly important that members of the healthcare team 
impress upon their patients the seriousness of timely screening, regardless of presence 
or absence of signs and symptoms, and potential consequences that may result if timely 
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screening does not happen. In a study done by Gupta, Brenner, Ratanawongsa, and 
Inadomi (2014), it was noted by the authors that a trusting relationship with a patient’s 
primary care provider can increase adherence to CRCS recommendations. The general 
definition of trust is the belief that the provider is truthful, caring, compassionate, and 
has the best interest of the patient at heart (Chandra, Mohammadnezhad, & Ward, 
2018). It is, therefore, critical that primary healthcare providers establish a trusting 
relationship with their patients if they want to see improved adherence with screening 
suggestions. According to Chandra, Mohammadnezhad, and Ward (2018), that trusting 
relationship can be established through effective communication, the way the provider 
treats the patient, and how well the provider demonstrates knowledge of the patient.  
Another opportunity would be electronic health maintenance reminders sent 
directly to both, the primary care providers and the patients who meet eligibility 
criteria, like age, time since previous CRCS, family history, personal history, or risk 
factors. Such information would need to be added to the electronic medical/health 
records by someone on the healthcare team and flagged for upcoming visits. The Office 
of the National Coordinator for Health Information Technology (ONC, 2019) noted that 
public health outcomes are enhanced with improved quality of care screenings for 
several chronic diseases through clinical alerts and reminders in the electronic health 
record (EHR). Other health maintenance reminders like vaccine boosters and 




 Public service announcements via television commercials, radio 
announcements, or advertisements on social media and in printed magazines are other 
means to increase awareness of colorectal cancer. There are plenty of public service 
announcements regarding breast cancer with the Susan B. Komen Foundation and their 
‘dress pink for breast cancer’ campaign as well as the designation of October being 
breast cancer awareness month and also tobacco cessation campaigns like ClearWay 
Minnesota’s QUITPLAN (2020) or the National Institute of Health’s smokefree.gov (n.d.), 
which includes free resources, tools, and tips for smokers who want to quit. Much less 
awareness is surrounded by the fact that March is colorectal cancer awareness month 
and the official color of the awareness ribbon is royal blue but not for the lack of 
availability of educational material. Public health agencies have a great opportunity to 
change the numbers of new colorectal cancer diagnoses and decrease deaths if they 
promote a campaign that appeals to all adults and helps mitigate fear of the test and 
similarly abate fear of the results. The ACG provides social media ready resources, some 
even separated to address men and women individually, that are easily accessible and 
can be used to promote CRCS. Having a way to focus on either sex separately makes it 
easier to alleviate concerns that are more insistent in women, as this study showed that 
women have greater barriers than men do.  
Unfortunately, the colon is a taboo subject for many people. Rendering CRCS a 
less stigmatized procedure by increasing awareness with bright and colorful ad 
campaigns can also decrease embarrassment, make it more acceptable, and increase 
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adherence. The ACG has ample resources available to accomplish that task. 
Furthermore, health insurance providers need to revise policies and procedures that 
make it easier for patients to receive CRCS so that financial constraints don’t end up 
having even more costly consequences. The ACS (2018) advocates for all patients to 
have access to screening established by evidence-based guidelines and regardless of 
insurance coverage. The current study points to not having insurance and the test being 
too expensive as a barrier for 35 participants, which is more than 20%, making this a 
significant hinderance. Unfortunately, every health insurance can determine what their 
own plans include and how much, if anything, the patients must pay in addition to what 
insurance covers. That makes it difficult to recommend specific changes since there is no 
uniformity, unless those changes are advocated for and effected in the political arena. 
Contacting local members of congress is a great option to start with.   
One more way to help with CRCS behavior change would be to add health and 
wellness coaches or care coordinators as regular and permanent members of the 
healthcare team. Langley (2019) notes that health coaches effect behavior changes by 
inspiring motivation and helping people build up self-care skills. Coaches collaborate 
with patients on patient-identified health goals, improvement of general well-being, and 
facilitation of lifestyle changes in a growing reliance and partnership with providers 
(Langley, 2019). Thom et al. (2016) related the benefits of health coaches as part of the 
healthcare team and stressed areas like development of a trusting relationship, personal 
and decision-making support, coaches being a bridge between patients and their 
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providers, and coach availability. Coaches could take over patient support of self-
management in areas such as health maintenance, medication compliance, 
recommended preventative measures like vaccines and screenings, and making changes 
in physical activity and stress reduction, effectively empowering the patients to take 
ownership in their own health and well-being. Gastala et al. (2018) remarked that 
“health coaches are behavior change specialists who partner with patients to identify 
goals and barriers, reinforce recommendations, and coordinate care” (p. 526). Adding 
health coaches to any health care team is, therefore a valuable asset and can help 
patients stay current on preventive screenings, like CRCS.  
Lastly, many see the prep and physical clearing of the colon as a barrier to 
getting screened. Unfortunately, having a clean colon is a prerequisite to CRCS and will 
remain necessary. Side effects can happen while doing a bowel prep because the body 
loses a lot of fluids and this can be uncomfortable and lead to dehydration, nausea, 
vomiting, and weakness. If that happens, proceduralists can add such information to the 
medical record triggering recommendations to add electrolytes and extra fluids on the 
fasting day to help alleviate side effects during subsequent preps and therefore making 
the bowel prep more tolerable.  
Recommendations for Future Research 
The survey was only open for three weeks on social media and distributed via 
postcard at two locations of a local gastroenterology clinic for two weeks, which did not 
yield the desired number of participants. To get a more appropriate representation of 
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the population with much higher numbers of participants, this survey needs to be 
distributed in a larger geographical area and be available for a longer time. This study 
also only focused on patients in a limited age group. However, in light of increasing 
numbers of colorectal cancer diagnoses in patients younger than 50, and the majority of 
cases on patients older than the participants, it might yield further important 
information to extend a survey such as this to other age groups.  
Males as well as ethnic and racial groups were underrepresented in this study. 
By expanding the geographic distribution of the survey, the racial distribution of 
participants could potentially be more consistent with that of the general American 
public. This survey was conducted on social media, and in middle-class suburban clinics, 
which likely did not get the same demographics and survey results we would see in 
more underprivileged areas of the country, making that another opportunity to look 
further into CRCS practices and barriers. In this regard, it might also be helpful to inquire 
about education level, income, and access to preventive care in general.  
When assessing CRCS practices, it may be helpful to address reasons why 
participants have had their first colonoscopy before the recommended starting age of 
45 or 50, which this study did not address. It would also be helpful to conduct pilot 
testing as one comment was made that the items that assessed attitudes did not make 
sense. Feedback about how the survey items are written understood can provide a 
valuable resource to assure higher participation by even those that are not very 
healthcare literate. Adding other CRCS methods that are much less prevalent will also 
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provide added awareness of screening practices that may not adhere to the norm and a 
distribution across demographics.  
Summary 
 While more women responded to the survey, men reported fewer perceived 
barriers. Future research needs to expand not only the time frame of the study and the 
geographical area to get a more diverse demographic but also include impact of socio-
economic status and underlying comorbidities as barriers to timely CRCS.  
This study did not yield the expected number of participants and the sample was 
not very diverse, yet there were some important findings that can have an impact on 
future healthcare practices as well as future research. Healthcare providers or other 
healthcare team members need to increase time spent on patient education and follow-
through. Colorectal cancer should not be treated any differently than prostate or breast 
cancer and more public health campaigns to that effect are needed to make sure 
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